PMID- 30229927 OWN - NLM STAT- MEDLINE DCOM- 20190211 LR - 20190215 IS - 1097-0096 (Electronic) IS - 0091-2751 (Linking) VI - 46 IP - 8 DP - 2018 Oct TI - Short-term effects of levosimendan on strain/strain rate markers in patients with nonischemic dilated cardiomyopathy. PG - 527-532 LID - 10.1002/jcu.22627 [doi] AB - OBJECTIVE: To investigate whether repetitive measurements of speckle tracking echocardiography (STE)-derived strain (S) and strain rate (SR) could reveal changes in left ventricular function in patients with nonischemic dilated cardiomyopathy treated with levosimendan. METHODS: We included 22 consecutive patients (age 53 +/-12 years) with an ejection fraction (EF) below 35% and New York Heart Association (NYHA) class III-IV symptoms that required intravenous inotropic support despite optimal medical therapy. The absence of any occlusive coronary artery disease was identified via previous coronary angiography in all patients. Echocardiographic variables, including strain/strain rate, and NYHA functional class, were evaluated before and after levosimendan infusion at the 72nd hour and one month. RESULTS: The strain and strain rate values for both left and right ventricles were observed to be increased NYHA functional class and left ventricular EF (P <.05). CONCLUSION: STE can successfully completed conventional echocardiography in the evaluation of patients with decompensated heart failure who were treated with levosimendan. CI - (c) 2018 Wiley Periodicals, Inc. FAU - Kiris, Tuncay AU - Kiris T AUID- ORCID: 0000-0001-9793-718X AD - Department of Cardiology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey. FAU - Avci, Eyup AU - Avci E AD - Cardiology Department, Balikesir University Faculty of Medicine, Balikesir, Turkey. LA - eng PT - Clinical Trial PT - Journal Article DEP - 20180919 PL - United States TA - J Clin Ultrasound JT - Journal of clinical ultrasound : JCU JID - 0401663 RN - 0 (Cardiotonic Agents) RN - 349552KRHK (Simendan) SB - IM MH - Adult MH - Aged MH - Cardiomyopathy, Dilated/diagnostic imaging/*drug therapy/physiopathology MH - Cardiotonic Agents/pharmacology/*therapeutic use MH - Echocardiography/*methods MH - Female MH - Humans MH - Male MH - Middle Aged MH - Simendan/pharmacology/*therapeutic use MH - Treatment Outcome MH - Ventricular Function, Left/*drug effects OTO - NOTNLM OT - levosimendan OT - nonischemic cardiomyopathy OT - strain/strain rate EDAT- 2018/09/20 06:00 MHDA- 2019/02/12 06:00 CRDT- 2018/09/20 06:00 PHST- 2017/12/13 00:00 [received] PHST- 2018/05/05 00:00 [revised] PHST- 2018/06/21 00:00 [accepted] PHST- 2018/09/20 06:00 [pubmed] PHST- 2019/02/12 06:00 [medline] PHST- 2018/09/20 06:00 [entrez] AID - 10.1002/jcu.22627 [doi] PST - ppublish SO - J Clin Ultrasound. 2018 Oct;46(8):527-532. doi: 10.1002/jcu.22627. Epub 2018 Sep 19.